S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)

Genmab A/S (GMAB) News Today

$29.16
+0.05 (+0.17%)
(As of 02/23/2024 ET)
SourceHeadline
globenewswire.com logoTransactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
globenewswire.com - February 23 at 5:50 PM
globenewswire.com logoGrant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab
globenewswire.com - February 23 at 5:35 PM
marketbeat.com logoQ1 2024 Earnings Estimate for Genmab A/S Issued By HC Wainwright (NASDAQ:GMAB)
marketbeat.com - February 23 at 7:17 AM
marketbeat.com logoGenmab A/S (NASDAQ:GMAB) Upgraded by BMO Capital Markets to Outperform
marketbeat.com - February 23 at 7:15 AM
MarketBeat logoQ4 2024 EPS Estimates for Genmab A/S (NASDAQ:GMAB) Lifted by Analyst
americanbankingnews.com - February 23 at 2:34 AM
markets.businessinsider.com logoGenmab (GMAB) Gets a Buy from Truist Financial
markets.businessinsider.com - February 23 at 1:28 AM
finance.yahoo.com logoGMAB Mar 2024 35.000 put
finance.yahoo.com - February 22 at 8:06 PM
marketbeat.com logoHC Wainwright Weighs in on Genmab A/S's Q4 2024 Earnings (NASDAQ:GMAB)
marketbeat.com - February 22 at 7:50 AM
MarketBeat logoGenmab A/S's (GMAB) "Buy" Rating Reaffirmed at HC Wainwright
americanbankingnews.com - February 21 at 3:38 AM
MarketBeat logoGenmab A/S's (GMAB) "Buy" Rating Reaffirmed at Truist Financial
americanbankingnews.com - February 21 at 3:38 AM
msn.com logoDenmark stocks lower at close of trade; OMX Copenhagen 20 down 1.27%
msn.com - February 21 at 2:17 AM
marketbeat.com logoGenmab A/S (NASDAQ:GMAB) Stock Rating Reaffirmed by Truist Financial
marketbeat.com - February 20 at 10:26 AM
marketbeat.com logoQRG Capital Management Inc. Buys Shares of 79,388 Genmab A/S (NASDAQ:GMAB)
marketbeat.com - February 20 at 7:04 AM
globenewswire.com logoTransactions in connection with share buy-back program
globenewswire.com - February 19 at 4:40 AM
MarketBeat logoEquities Analysts Issue Forecasts for Genmab A/S's Q1 2024 Earnings (NASDAQ:GMAB)
americanbankingnews.com - February 19 at 1:36 AM
MarketBeat logoResearch Analysts Set Expectations for Genmab A/S's Q1 2024 Earnings (NASDAQ:GMAB)
americanbankingnews.com - February 19 at 1:36 AM
finance.yahoo.com logoGMAB Mar 2024 30.000 call
finance.yahoo.com - February 18 at 7:46 PM
MarketBeat logoGenmab A/S (NASDAQ:GMAB) and Earth Science Tech (OTCMKTS:ETST) Head-To-Head Analysis
americanbankingnews.com - February 18 at 3:20 AM
finance.yahoo.com logoGMAB Mar 2024 25.000 put
finance.yahoo.com - February 17 at 1:31 PM
MarketBeat logoQ4 2023 EPS Estimates for Genmab A/S (NASDAQ:GMAB) Decreased by Analyst
americanbankingnews.com - February 16 at 2:20 AM
MarketBeat logoGenmab A/S (NASDAQ:GMAB) to Post FY2023 Earnings of $1.03 Per Share, Leerink Partnrs Forecasts
americanbankingnews.com - February 16 at 1:26 AM
MarketBeat logoGenmab A/S (NASDAQ:GMAB) Shares Gap Up to $27.59
americanbankingnews.com - February 15 at 3:50 PM
marketbeat.com logoLeerink Partnrs Comments on Genmab A/S's FY2023 Earnings (NASDAQ:GMAB)
marketbeat.com - February 15 at 7:37 AM
globenewswire.com logoNotice to Convene the Annual General Meeting of Genmab A/S
globenewswire.com - February 15 at 6:00 AM
finance.yahoo.com logoGMAB Feb 2024 25.000 put
finance.yahoo.com - February 15 at 12:10 AM
finance.yahoo.com logoGenmab Publishes 2023 Annual Report
finance.yahoo.com - February 14 at 2:09 PM
finance.yahoo.com logoGenmab Announces Initiation of Share Buy-Back Program
finance.yahoo.com - February 14 at 2:09 PM
globenewswire.com logoGenmab Files Annual Report with the U.S. Securities and Exchange Commission
globenewswire.com - February 14 at 2:09 PM
globenewswire.com logoGenmab Announces Initiation of Share Buy-Back Program
globenewswire.com - February 14 at 11:41 AM
globenewswire.com logoGenmab Publishes 2023 Annual Report
globenewswire.com - February 14 at 11:02 AM
marketbeat.com logoQ4 2023 EPS Estimates for Genmab A/S Reduced by Leerink Partnrs (NASDAQ:GMAB)
marketbeat.com - February 14 at 7:42 AM
msn.com logoDenmark stocks lower at close of trade; OMX Copenhagen 20 down 0.25%
msn.com - February 13 at 8:32 PM
marketbeat.com logoGenmab A/S (NASDAQ:GMAB) Reaches New 12-Month Low at $26.61
marketbeat.com - February 13 at 11:28 AM
markets.businessinsider.com logoMaintaining Hold on Genmab: Balancing Darzalex Success with GEN3014’s Uncertain Future and Competitive Market Risks
markets.businessinsider.com - February 13 at 9:25 AM
MarketBeat logoGenmab A/S (GMAB) Set to Announce Quarterly Earnings on Wednesday
americanbankingnews.com - February 13 at 3:06 AM
marketbeat.com logoJ.P. Morgan Private Wealth Advisors LLC Invests $1.35 Million in Genmab A/S (NASDAQ:GMAB)
marketbeat.com - February 12 at 5:16 AM
marketbeat.com logoGenmab A/S (GMAB) to Release Earnings on Wednesday
marketbeat.com - February 7 at 4:12 AM
marketbeat.com logo32,732 Shares in Genmab A/S (NASDAQ:GMAB) Acquired by Keybank National Association OH
marketbeat.com - February 6 at 6:19 AM
marketbeat.com logoGenmab A/S (NASDAQ:GMAB) Shares Bought by Atria Investments Inc
marketbeat.com - February 4 at 5:24 AM
morningstar.com logoGenmab A/S ADR GMAB
morningstar.com - February 2 at 3:37 PM
markets.businessinsider.com logoGenmab: EMA To Review MAA Of Tisotumab Vedotin - Quick Facts
markets.businessinsider.com - February 2 at 10:36 AM
msn.com logoJ&J seeks expanded FDA approval of Darzalex Faspro for multiple myeloma
msn.com - February 1 at 10:39 PM
marketbeat.com logoGenmab A/S (NASDAQ:GMAB) Expected to Post Q4 2023 Earnings of $0.32 Per Share
marketbeat.com - February 1 at 6:04 AM
realmoney.thestreet.com logoGenmab price target raised by $1 at H.C. Wainwright, here's why
realmoney.thestreet.com - January 29 at 10:09 AM
marketbeat.com logoGenmab A/S (NASDAQ:GMAB) Price Target Raised to $50.00 at HC Wainwright
marketbeat.com - January 29 at 8:19 AM
marketbeat.com logoWilliam Blair Analysts Boost Earnings Estimates for Genmab A/S (NASDAQ:GMAB)
marketbeat.com - January 26 at 8:41 AM
marketbeat.com logoFY2023 EPS Estimates for Genmab A/S (NASDAQ:GMAB) Increased by William Blair
marketbeat.com - January 25 at 6:52 AM
finanznachrichten.de logoGenmab A/S: Genmab Announces Decision in Arbitration Appeal under License Agreement with Janssen
finanznachrichten.de - January 24 at 7:34 PM
seekingalpha.com logoGenmab's Arbitration Loss: Best To Forgive And Forget (Rating Upgrade)
seekingalpha.com - January 23 at 6:32 PM
finance.yahoo.com logoGenmab Announces Net Sales of DARZALEX® (daratumumab) for 2023
finance.yahoo.com - January 23 at 8:31 AM
Get Genmab A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMAB and its competitors with MarketBeat's FREE daily newsletter.



GMAB Media Mentions By Week

GMAB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GMAB
News Sentiment

0.20

0.46

Average
Medical
News Sentiment

GMAB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GMAB Articles
This Week

30

4

GMAB Articles
Average Week

Get Genmab A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMAB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:GMAB) was last updated on 2/23/2024 by MarketBeat.com Staff